UK: Cannon and Riall to headline at Medica
Andrew Cannon is joining Medica, the UK-based provider of teleradiology and telepathology services for NHS-partnered customers and patients. Tom Riall has joined as chair....
UK: Fresh appointments at SV Health Investors
SV Health Investors, a transatlantic venture capital and growth equity firm, is bolstering its senior biotech team with the appointments of Nikola Trbovic as...
UK: DBJ makes first investment into a UK life sciences fund
4BIO Capital, an international VC investing in advanced therapies and other emerging technologies, has entered into an investment agreement with the Development Bank of...
The Netherlands: Carl Zeiss Meditec acquires DORC from Eurazeo
Carl Zeiss Meditec has entered into an agreement to acquire 100% of the shares in DORC (Dutch Ophthalmic Research Center) from France-based investors, Eurazeo,...
Rising importance of ESG to APAC medtech
ESG initiatives are increasingly prioritized by Asia Pacific medtech companies and their customers, according to a survey conducted jointly by Bain & Company and...
Investing in strength, building scale: outlook for European healthcare focused PE and VC investors
In November 2023, global management consultancy Arthur D Little (ADL) and Invest Europe’s European PE survey, combined with Invest Europe’s first half activity data,...
Sweden: Koch announced as new CFO at Prostatype Genomics
Prostatype Genomics, a company that offers prostate cancer patients decision support for the most optimal treatment option, has appointed Anders Koch as its new CFO...
Precision robots revolutionising human healthcare
Society faces an increasing number of technological relationship decisions, not least the pressing question of whether labour shortfalls should be met by automation, migrants,...
Asia’s healthcare private equity market comes of age
Private equity investments in Asia-Pacific’s healthcare sector bucked a global slowdown in activity during 2022. An increasing number of large deals points to the...
A strategic look at Asian healthcare M&A. Investors in Healthcare talks to Bain &...
Global healthcare M&A volumes dropped in 2022, but the long-term underlying drivers remain strong. Hopes are that deal activity will pick up through 2023....
Advertisement
